WASHINGTON (MedPage Today) — The House and Senate have adjourned for their summer recess, but an FDA advisory panel met on an epilepsy drug, and there’s been activity on the healthcare reform front.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has notified healthcare professionals and consumers of a number of counterfeit copies of military-grade tourniquets which may break or fail to function as well as the original.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has notified healthcare professionals and consumers of a number of counterfeit copies of military-grade tourniquets which may break or fail to function as well as the original.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — The emergency contraceptive drug ulipristal acetate (ella) can be marketed in the U.S. for preventing pregnancy up to five days after unprotected sex, the FDA said.
No Comments »
Filed under: Pharmacy News
Bristol-Myers Squibb Company (NYSE: BMY) and the ADAP Crisis Task Force (ACTF) announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs (ADAPs) to provide antiretroviral medicines to people living with HIV and AIDS…
No Comments »
Filed under: Pharmacy News
The U.S. Food and Drug Administration approved ella™ (ulipristal acetate) tablets for emergency contraception. The prescription-only product prevents pregnancy when taken orally within 120 hours (five days) after a contraceptive failure or unprotected intercourse. It is not intended for routine use as a contraceptive…
No Comments »
Filed under: Pharmacy News
A new morning after pill, also known as an emergency contraception pill, called Ella (ulipristal acetate) has been approved in tablet form by the US Food and Drug Administration (FDA). It has been approved as a prescription-only-product, and prevents pregnancy if taken within five days after unprotected sexual intercourse or contraceptive failure…
No Comments »
Filed under: Women's Health
Weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations…
No Comments »
Filed under: Women's Health
Peoples’ access across England to total joint replacement of the hip or knee is uneven and affected unfairly by age, sex, deprivation, geography and ethnicity, according to a new study published on http://bmj.com/. The results show that women, elderly people, and those in deprived areas continue to be worse off…
No Comments »
Filed under: Women's Health
University of Alberta researcher Brea Malacad says results from a study on oral sex indicate there is little doubt that oral sex is becoming a more common activity for young women. Study results show the act has become a fundamental part of what Malacad calls the “sexual revolution of the 21st century”…
No Comments »
Filed under: Women's Health
